SUMOylation indirectly suppresses activity of the HIF-1α pathway in intestinal epithelial cells
Journal of Biological Chemistry · 2023
DOI: 10.1016/j.jbc.2023.105280 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2023. Verfasst von Mykyta I Malkov und 2 weiteren Autor:innen. Beteiligte Einrichtung: Conway Institute of Biomolecular and Biomedical Research and School of Medicine, University College Dublin, Belfield, Ireland. Hauptthemen laut MEDLINE: Epithelial Cells, Hypoxia-Inducible Factor 1, alpha Subunit, Sumoylation. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University College Dublin.
Abstract (Originalsprache)
The hypoxia-inducible factor (HIF) is a master regulator of the cellular transcriptional response to hypoxia. While the oxygen-sensitive regulation of HIF-1α subunit stability via the ubiquitin-proteasome pathway has been well described, less is known about how other oxygen-independent post-translational modifications impact the HIF pathway. SUMOylation, the attachment of SUMO (small ubiquitin-like modifier) proteins to a target protein, regulates the HIF pathway, although the impact of SUMO on HIF activity remains controversial. Here, we examined the effects of SUMOylation on the expression pattern of HIF-1α in response to pan-hydroxylase inhibitor dimethyloxalylglycine (DMOG) in intestinal epithelial cells. We evaluated the effects of SUMO-1, SUMO-2, and SUMO-3 overexpression and inhibition of SUMOylation using a novel selective inhibitor of the SUMO pathway, TAK-981, on the sensitivity of HIF-1α in Caco-2 intestinal epithelial cells. Our findings demonstrate that treatment with TAK-981 decreases global SUMO-1 and SUMO-2/3 modification and enhances HIF-1α protein levels, whereas SUMO-1 and SUMO-2/3 overexpression results in decreased HIF-1α protein levels in response to DMOG. Reporter assay analysis demonstrates reduced HIF-1α transcriptional activity in cells overexpressing SUMO-1 and SUMO-2/3, whereas pretreatment with TAK-981 increased HIF-1α transcriptional activity in response to DMOG. In addition, HIF-1α nuclear accumulation was decreased in cells overexpressing SUMO-1. Importantly, we showed that HIF-1α is not directly SUMOylated, but that SUMOylation affects HIF-1α stability and activity indirectly. Taken together, our results indicate that SUMOylation indirectly suppresses HIF-1α protein stability, transcriptional activity, and nuclear accumulation in intestinal epithelial cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Conway Institute of Biomolecular and Biomedical Research and School of Medicine, University College Dublin, Belfield, Ireland.
- Conway Institute of Biomolecular and Biomedical Research and School of Medicine, University College Dublin, Belfield, Ireland. Electronic address: cormac.taylor@ucd.ie.
Förderung
- University College Dublin
Zitieren
APA
Malkov, M. I., Flood, D., & Taylor, C. T. (2023). SUMOylation indirectly suppresses activity of the HIF-1α pathway in intestinal epithelial cells. Journal of Biological Chemistry. https://doi.org/10.1016/j.jbc.2023.105280
Vancouver
Malkov MI, Flood D, Taylor CT. SUMOylation indirectly suppresses activity of the HIF-1α pathway in intestinal epithelial cells. Journal of Biological Chemistry. 2023. doi:10.1016/j.jbc.2023.105280
BibTeX
@article{Malkov2023,
author = {Malkov, Mykyta I and Flood, Darragh and Taylor, Cormac T},
title = {SUMOylation indirectly suppresses activity of the HIF-1α pathway in intestinal epithelial cells},
journal = {Journal of Biological Chemistry},
year = {2023},
doi = {10.1016/j.jbc.2023.105280}
}
EUVIMED